Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements

Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling. 2023-10-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyguidance for applicantsseeking authorizationdrug-clinical-trialsconduct COVID-19 drug-clinical-trialsthe Regulationsadditional requirements Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/covid-19-regulations/additional-requirements.html Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/covid-19-reglement/exigences-supplementaires.html

This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.

Data and Resources

Similar records